Drug Design, Development and Therapy (May 2019)
Ferulic acid attenuates liver fibrosis and hepatic stellate cell activation via inhibition of TGF-β/Smad signaling pathway [Corrigendum]
Abstract
Mu M, Zuo S, Wu RM, et al. Drug Des Devel Ther. 2018;12:4107–4115. An error has been found in a couple of the image labels for Figure 3F. On page 4112, the original Figure 3F image appears as: Read the original article:
